FORMULATIONS OF PTHrP ANALOGUES, TRANSDERMAL PATCHES THEREOF, AND USES THEREOF
Disclosed are PTHrP analogue formulations for transdermal delivery of a therapeutically effective amount of a PTHrP analogue, as well as transdermal patches prepared using these formulations, methods of preparing the disclosed formulations and patches, and methods of using these formulations and patches to treat osteoporosis, osteopenia, osteoarthritis, and/or bone fracture, improve bone mineral density (BMD), improve trabecular bone score (TBS), and treat, prevent, and/or reduce bone fractures..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Europäisches Patentamt - (2023) vom: 07. Sept. Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
HATTERSLEY GARY [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-09-07, Last update posted on www.tib.eu: 2023-09-28, Last updated: 2023-10-06 |
---|
Patentnummer: |
US2023277444 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA018090079 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | EPA018090079 | ||
003 | DE-627 | ||
005 | 20231006120417.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231006s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA018090079 | ||
035 | |a (EPA)US2023277444 | ||
035 | |a (EPA)57223759 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a HATTERSLEY GARY |e verfasserin |4 aut | |
245 | 1 | 0 | |a FORMULATIONS OF PTHrP ANALOGUES, TRANSDERMAL PATCHES THEREOF, AND USES THEREOF |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2023-09-07, Last update posted on www.tib.eu: 2023-09-28, Last updated: 2023-10-06 | ||
520 | |a Disclosed are PTHrP analogue formulations for transdermal delivery of a therapeutically effective amount of a PTHrP analogue, as well as transdermal patches prepared using these formulations, methods of preparing the disclosed formulations and patches, and methods of using these formulations and patches to treat osteoporosis, osteopenia, osteoarthritis, and/or bone fracture, improve bone mineral density (BMD), improve trabecular bone score (TBS), and treat, prevent, and/or reduce bone fractures. | ||
650 | 4 | |a che | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
650 | 4 | |a 615 | |
700 | 0 | |a HARRIS ALAN |4 aut | |
700 | 0 | |a SAEH JAMAL |4 aut | |
700 | 0 | |a HAMED EHAB |4 aut | |
700 | 0 | |a BROWN KENNETH |4 aut | |
700 | 0 | |a DOHMEIER DANIEL |4 aut | |
700 | 0 | |a MOSEMAN JOAN |4 aut | |
700 | 0 | |a ZHANG YING |4 aut | |
700 | 0 | |a DICK LISA |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 07. Sept. |
773 | 1 | 8 | |g year:2023 |g day:07 |g month:09 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/57223759/publication/US2023277444A1?q=US2023277444 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
936 | u | w | |j 2023 |b 07 |c 09 |
951 | |a AR | ||
952 | |j 2023 |b 07 |c 09 |